Blood Cancer United
Treating Blood Cancers
Podcast series for professionals by Blood Cancer United
Be sure to visit the podcast's website and support the creator: treatingbloodcancers.org
Author
Blood Cancer United
Category
Podcast website
Latest episode
Nov 13, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
Shared Decision Making with Your Patients Diagnosed with a Chronic Leukemia: Part I 17.02.2022 33:15
Jacqueline C. Barrientos, MD, MS, Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY Recorded on February 1, 2022 Jacqueline C. Barrientos, MD, MS Professor of Medicine Zucker School of Medicine at Hofstra/Northwell CLL Research & Treatment Program Hempstead, NY Shared decision making between patients and their healthcare team is an important component to treatment, regardless of th...
CAR T-cell Therapy in 2022: What You Need to Know 25.01.2022 41:55
Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA Recorded on January 4, 2022 Caron Jacobson, MD Assistant Professor of Medicine Harvard Medical School Medical Director Immune Effector Cell Therapy Program Dana-Farber Cancer Institute Boston, MA As we move into 2022, chimeric antigen receptor (CAR) T-cell therapy continues to be a very exciting and effective treatment option for some bl...
Highpoints from Attending the 2021 American Society of Hematology Conference 12.01.2022 43:38
Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY Recorded on December 22, 2021 Each year, blood cancer professionals gather at the American Society of Hematology Annual Meeting to discuss the latest updates in blood cancer research, treatment, and clinical trials. In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia &...
Updates on COVID-19 in Patients with Blood Cancer 20.12.2021 28:54
John P. Leonard, MD, Weill Cornell Medicine, New York Presbyterian, New York, NY Recorded on December 16, 2021 As 2021 comes to a close, the COVID-19 pandemic continues to evolve. In this episode, Dr. John Leonard, from Weill Cornell Medicine, New York Presbyterian Hospital, discusses the latest updates on how COVID-19 affects the blood cancer patient population. What is the value of the vaccine i...
A Conversation on Adult Survivorship 17.11.2021 38:34
Maria Alma Rodriguez, MD, MACP, CMQ, The University of Texas MD Anderson Cancer Center, Houston, TX Recorded on October 21, 2021 In this episode, Dr. Maria Alma Rodriguez from The University of Texas MD Anderson Cancer Center, joins us in discussing the long-term and late effects of cancer treatment, including strategies to support survivors with physical and psychosocial effects. Dr. Rodriguez de...
The Advanced Practice Provider’s Role in Treating Newly Diagnosed Patients with Myeloma 19.10.2021 41:34
Daniel Verina, DNP, ACNP-BC, Mount Sinai Medical Center, New York, NY Recorded on October 1, 2021 Advanced practice providers, nurses, and other members of the multidisciplinary healthcare team play an important role in treating and supporting newly diagnosed myeloma patients. In this month’s episode, Daniel Verina, DNP, ACNP-BC, Acute Care Nurse Practitioner, Multiple Myeloma Program, at the Moun...
The Physician’s Role in Treating Newly Diagnosed Patients with Myeloma 11.10.2021 38:33
Joshua Richter, MD, Icahn School of Medicine at Mount Sinai, New York, NY Recorded on September 10, 2021 Treating myeloma patients, especially newly diagnosed, can be very complex. How are treatment decisions determined? Who is eligible to receive a transplant? What is the patient’s role in making treatment decisions? In this month’s episode, Dr. Joshua Richter from the Icahn School of Medicine at...
Clinical Trials: A Healthcare Professional’s Perspective 30.09.2021 28:25
Lorenzo Falchi, MD and Leah Szumita, MS, RN, CCRN, ACNS-BC Recorded on August 5, 2021 Clinical trials are the foundation of advancing treatment options. Understanding their importance, dispelling myths and fears about enrollment, and acknowledging disparities in access can help providers educate their patients and discuss treatment in a clinical trial as an option at any point in the patient’s can...
Wearing Two Hats: Supporting the Childhood Cancer Patient as Nurse & Parent 01.09.2021 28:57
David Tate, BSN, RN, PHN, Rio Bravo-Greeley School, Bakersfield, CA Recorded on August 11, 2021 September is Childhood Cancer Awareness Month, a time to recognize the children and families affected by blood cancer. In this month’s special episode, we are joined by David Tate, a registered nurse in the Rio Bravo-Greeley School system in Bakersfield, California to discuss his journey from the father...
Addressing Healthcare Disparities in Cancer Care 18.08.2021 23:16
Justine M. Kahn, MD, MS, Columbia University Irving Medical Center, New York, NY Recorded on July 13, 2021 Healthcare disparities are a known factor in cancer care. Understanding these disparities can enable healthcare professionals to more effectively communicate with and treat their patients. In this episode, Dr. Justine Kahn, from the Herbert Irving Comprehensive Cancer Center at Columbia Unive...
T-cell Lymphoma: A Discussion on Treatment and Patient Support 19.07.2021 28:10
Steven Horwitz, MD, Memorial Sloan Kettering Cancer Center, New York, NY Recorded on June 18, 2021 Tune in to this very informative and interesting conversation on T-cell lymphoma! Dr. Steven Horwitz, from Memorial Sloan Kettering Cancer Center in New York City, discusses types and diagnostic tests used to identify T-cell lymphoma, goals of treatment, approved and emerging treatment options, inclu...
A Discussion on MRD: Practical Information for Providers 22.06.2021 27:42
Jeffrey L. Wolf, MD, University of California San Francisco, San Francisco, CA Recorded on May 27, 2021 In this episode, Dr. Jeffrey Wolf, from the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California San Francisco, explains what measurable residual disease (MRD) is, how providers can explain the role of MRD to patients, including understanding the tests used, how t...
A Deeper Dive into Cancer Genomics 26.05.2021 29:09
Justin M. Watts, MD, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL Recorded on May 14, 2021 Terminology, available tests, the impact of epigenetics, and the significance of mutations. Understanding the role of genomics in cancer care can be complex. Tune in as Dr. Justin Watts from the Sylvester Comprehensive Cancer Center in Miami, breaks down cancer genomics, discusses th...
The Pharmacist’s Role on the Blood Cancer Treatment Team 06.05.2021 39:45
Peter Campbell, PharmD, BCOP, Columbia University Irving Medical Center, New York, NY Recorded on April 23, 2021 The interprofessional oncology team is comprised of many healthcare professionals, each playing an important role in contributing to a patient’s care. Join Dr. Peter Campbell, Clinical Pharmacy Manager from Columbia University Irving Medical Center, as he discusses the vital role of pha...
A Conversation on Multiple Myeloma with Edward Stadtmauer, MD 23.03.2021 35:03
Edward A. Stadtmauer, MD, The University of Pennsylvania, Philadelphia, PA Recorded on February 23, 2021 In recognition of March being Myeloma Awareness Month, The Leukemia & Lymphoma Society is pleased to share this informative podcast episode on updates and advancements in multiple myeloma. Healthcare professionals are challenged to stay up-to-date on new and emerging treatments options, inc...
The COVID-19 Vaccine and Your Patient with Cancer 10.03.2021 35:56
Michael Angarone, DO, FIDSA, Feinberg School of Medicine, Chicago, IL Recorded on February 25, 2021 There are so many questions cancer patients and their families have about the COVID-19 vaccine. What are the differences between the vaccines available? How do they work? Who should get vaccinated? Can one resume activities once vaccinated? This important podcast episodes aims to dispel myths surrou...
Managing Treatment for Patients with Relapsed/Refractory Lymphoma 24.02.2021 31:33
Sonali M. Smith, MD, FASCO, The University of Chicago, Chicago, IL Recorded on January 25, 2021 How do we start the conversation? How do we discuss patient expectation and the likelihood of relapse? What role does the timing of relapse play? In this episode, Dr. Sonali Smith, the Elwood V. Jensen Professor of Medicine at The University of Chicago, discusses expectations for disease control and for...
What’s New in Treatment for Acute Myeloid Leukemia (AML) 03.02.2021 39:31
Olatoyosi Odenike, MD and Wendy Stock, MD Recorded on January 15, 2021 Join Drs. Wendy Stock and Olatoyosi Odenike from The University of Chicago Medicine, in an important discussion on the progress in the treatment of acute myeloid leukemia, including important updates from the LLS Beat AML Master Trial. Drs. Stock and Odenike talk with Dr. Ken Miller about determining a treatment plan for each p...
Progress in the Treatment of Follicular Lymphoma 20.01.2021 27:42
Jeff Sharman, MD, Willamette Valley Cancer Institute, Eugene, OR Recorded on December 14, 2020 What is follicular lymphoma and how does it differ from other indolent lymphomas? Can this cancer be cured? Join Dr. Ken Miller as he speaks with Dr. Jeff Sharman, Director of Research at Willamette Valley Cancer Institute and Medical Director of Hematology Research for The US Oncology Network to discuss...
Current Applications of Cancer Genomics: Focus on CLL 15.12.2020 33:20
Jennifer Brown, MD, PhD, Dana-Farber Cancer Institute, Boston, MA Recorded on November 19, 2020 Morphology was once the only means of classifying blood cancers especially CLL; flow cytometry, cytogenetics and immunohistochemistry all followed. With a revolution in understanding, there is now a growing list of molecular tests that provide even more precise diagnostic and prognostic tools in diagnos...
Supporting LGBTQI Cancer Patients 17.11.2020 27:50
Matthew B. Schabath, PhD, Moffitt Cancer Center, Tampa, FL Recorded on November 2, 2020 Individuals in the LGBTQI community face many barriers in accessing healthcare. In this episode, Dr. Matthew Schabath from the Moffitt Cancer Center addresses ways healthcare professionals can be more competent in supporting persons within this community. Dr. Schabath breaks down the terminology and stakeholder...
A Deeper Dive into MRD: A Conversation with Gail Roboz, MD 19.10.2020 45:10
Gail J. Roboz, MD, Weill Cornell Medical College, New York, NY Recorded on October 2, 2020 Minimal/measurable residual disease (MRD) refers to the small number of cancer cells that remain in the body after treatment. In this episode, Gail Roboz, MD, from Weill Cornell Medical College, provides an overview of MRD, including understanding its definition, explains the role advancements in technology...
Communicating with Caregivers: Strategies for HCPs 22.09.2020 32:17
Allison J. Applebaum, Ph. D., Memorial Sloan Kettering Cancer Center, New York, NY Recorded on June 26, 2020 Caregivers of patients diagnosed with cancer often don’t allow themselves to connect to the negative emotions that arise. Discussion with Dr. Allison Applebaum focuses on the importance of coaching caregivers to ask for help, problem solve, formulate questions to ask the oncologist, have po...
Communicating with the Young Adult with Blood Cancer 03.09.2020 32:52
Carma Bylund, PhD, FACH, and Carla Fisher, PhD Recorded on August 13, 2020 Young adults (YAs) are navigating physical, cognitive, and psychological changes, and transitioning into a more independent time of their life including social life and making more decisions on their own. They often grapple with unique issues when faced with a cancer diagnosis. Carma Bylund, PhD, FACH and Carla Fisher, PhD...
Facilitating the Learning Experience of Children and AYAs During and After Cancer Treatment 10.08.2020 34:23
Nicole Gutman, MS, and Mary Kay Irwin, EdD Recorded on May 19, 2020 Children, adolescents, and young adults (AYAs) face unique challenges when returning to school during or after cancer treatment. In this episode, Nicole Gutman, MS, a School Intervention Consultant, and Mary Kay Irwin, EdD, Director of School Health, at Nationwide Children’s Hospital, describe the psychosocial, educational, and co...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.